Insider · CIK 0001941313

Baranick Brian

Reports to the SEC for 1 company · MADISON, WI

sec.gov

Transactions

Companies

Filings

CIK

0001941313

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsD Disposition to Issuer	EVP, GM, Precision Oncology	DDisposition to Issuer	−28.1K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPA Award	EVP, GM, Precision Oncology	AAward	+33.3K sh	—	—	137,195
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	EVP, GM, Precision Oncology	DDisposition to Issuer	−137K sh	—	—	0
2026-03-23	EXASEXACT SCIENCES CORPD Disposition to Issuer	EVP, GM, Precision Oncology	DDisposition to Issuer	−795 sh	—	—	0
2026-02-25	EXASEXACT SCIENCES CORP · Restricted Stock UnitsA Award	EVP, GM, Precision Oncology	AAward	+28.1K sh	—	—	28,063
2025-12-24	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−14.9K sh	$101.59	−$1.52M	103,874
2025-12-24	EXASEXACT SCIENCES CORPA Award	EVP, GM, Precision Oncology	AAward	+29.4K sh	—	—	118,812
2025-12-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−9,450 sh	—	—	0
2025-12-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−28.8K sh	—	—	0
2025-12-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−16.1K sh	—	—	0
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−21.6K sh	$101.82	−$2.2M	79,265
2025-12-23	EXASEXACT SCIENCES CORPA Award	EVP, GM, Precision Oncology	AAward	+20.6K sh	—	—	99,849
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−10.5K sh	$101.82	−$1.06M	89,396
2025-12-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−14.8K sh	—	—	0
2025-12-23	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−3,955 sh	—	—	0
2025-12-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+3,955 sh	—	—	26,323
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,009 sh	$101.82	−$205K	24,314
2025-12-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+9,450 sh	—	—	33,764
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−4,799 sh	$101.82	−$489K	28,965
2025-12-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+14.8K sh	—	—	43,810
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−7,539 sh	$101.82	−$768K	36,271
2025-12-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+28.8K sh	—	—	65,050
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−14.6K sh	$101.82	−$1.49M	50,436
2025-12-23	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+16.1K sh	—	—	66,487
2025-12-23	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−8,151 sh	$101.82	−$830K	58,336
2025-12-23	EXASEXACT SCIENCES CORPA Award	EVP, GM, Precision Oncology	AAward	+42.5K sh	—	—	100,859
2025-11-04	EXASEXACT SCIENCES CORPS Sale	EVP, GM, Precision Oncology	SSale	−2,858 sh	$70.08	−$200K	22,368
2025-08-05	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−5,350 sh	—	—	16,051
2025-08-05	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,717 sh	$46.83	−$127K	25,226
2025-08-05	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+5,350 sh	—	—	27,943
2025-02-28	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,513 sh	$47.82	−$120K	22,593
2025-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+4,725 sh	—	—	22,558
2025-02-28	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,400 sh	$47.82	−$115K	20,158
2025-02-28	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+4,948 sh	—	—	25,106
2025-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−4,725 sh	—	—	9,450
2025-02-28	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−4,948 sh	—	—	14,845
2025-02-25	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+3,954 sh	—	—	19,841
2025-02-25	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,008 sh	$51.28	−$103K	17,833
2025-02-25	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−3,954 sh	—	—	3,955
2025-02-24	EXASEXACT SCIENCES CORP · Restricted Stock UnitsA Award	EVP, GM, Precision Oncology	AAward	+28.8K sh	—	—	28,779
2025-02-20	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−2,437 sh	$50.48	−$123K	15,887
2025-02-20	EXASEXACT SCIENCES CORPA Award	EVP, GM, Precision Oncology	AAward	+4,805 sh	—	—	18,324
2025-02-19	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+1,729 sh	—	—	14,487
2025-02-19	EXASEXACT SCIENCES CORPF Tax Payment	EVP, GM, Precision Oncology	FTax Payment	−968 sh	$49.63	−$48K	13,519
2025-02-19	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−1,729 sh	—	—	0
2024-10-08	EXASEXACT SCIENCES CORPS Sale	EVP, GM, Precision Oncology	SSale	−929 sh	$70.00	−$65K	12,758
2024-09-18	EXASEXACT SCIENCES CORPS Sale	EVP, GM, Precision Oncology	SSale	−929 sh	$70.00	−$65K	13,687
2024-08-05	EXASEXACT SCIENCES CORPM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	+2,712 sh	—	—	15,991
2024-08-05	EXASEXACT SCIENCES CORP · Restricted Stock UnitsA Award	EVP, GM, Precision Oncology	AAward	+21.4K sh	—	—	21,401
2024-08-05	EXASEXACT SCIENCES CORP · Restricted Stock UnitsM Exercise/Conversion	EVP, GM, Precision Oncology	MExercise/Conversion	−2,712 sh	—	—	0

Recent filings

Accepted (ET)
Mar 234
Baranick Brian0001193125-26-118765
SEC(opens sec.gov)
Feb 274
Baranick Brian0001193125-26-082836
SEC(opens sec.gov)
Dec 304
Baranick Brian0001193125-25-337155
SEC(opens sec.gov)

Companies

EXACT SCIENCES CORPEVP, GM, Precision OncologyEXAS

Address

C/O EXACT SCIENCES CORP. 5505 ENDEAVOR LANE

MADISON, WI, 53719